<"DNDN has said that if they get better than 0.05 but worse than the interim alpha..... they will submit to the FDA for approval again"> Have they actually COMMITTED to doing that ???? I think that would be asking the FDA to set aside a more fundamental precedent than what was asked earlier this year. My mind goes off on a tangent..... .....expressions like "stock-price management" (Elan CEO in reference to NRMX CEO) come to mind.